Hi @ddwn,
and to answer your question: ' Does a properly run trial always = RCT? '
No. It doesn't. This is the reddest of herrings.
I'd encourage all MSB holders to download the PDF and read in detail the following pithily relevant research article as published in the British Medical Journal:
https://www.bmj.com/content/bmj/363/bmj.k5094.full.pdf
Cheers,
See you all at the AGM
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-111
-
- There are more pages in this discussion • 252 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.501B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |